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Introduction: This study tested the hypothesis that cyclosporine (CsA)-supported syngeneic adipose-derived
mesenchymal stem cell (ADMSC) therapy offered superior attenuation of acute ischemia–reperfusion (IR) kidney
injury to either therapy alone.
Methods: Adult Sprague–Dawley rats (n = 40) were equally divided into group 1 (sham controls), group 2 (IR
injury), group 3 (IR + CsA (20 mg/kg at 1 and 24 hours after procedure)), group 4 (syngeneic ADMSC (1.2×106) at 1,
6 and 24 hours after procedure), and group 5 (IR + CsA-ADMSC).
Results: By 72 hours after the IR procedure, the creatinine level and the ratio of urine protein to creatinine were
highest in group 2 and lowest in group 1, and significantly higher in groups 3 and 4 than in group 5 (all P <0.05
for inter-group comparisons), but showed no differences between groups 3 and 4 (P >0.05). The inflammatory
biomarkers at mRNA (matrix metalloproteinase-9, RANTES, TNF-α), protein (TNF-α, NF-κB, intercellular adhesion
molecule-1, platelet-derived growth factor), and cellular (CD68+) levels of IR kidney showed a similar pattern
compared with that of creatinine in all groups (all P <0.05 for inter-group comparisons). The protein expressions
of oxidative stress (oxidized protein), reactive oxygen species (NADPH oxidases NOX-1, NOX-2), apoptosis
(Bcl-2–associated X protein, caspase-3 and poly(ADP-ribose) polymerase) and DNA damage (phosphorylated H2A
histone family member X-positive, proliferating cell nuclear antigen-positive cells) markers exhibited a pattern
similar to that of inflammatory mediators amongst all groups (all P <0.05 for inter-group comparisons). Expressions
of antioxidant biomarkers at cellular (glutathione peroxidase, glutathione reductase, heme oxygenase-1 (HO-1))
and protein (NADPH dehydrogenase (quinone)-1, HO-1, endothelial nitric oxide synthase) levels, and endothelial
progenitor cell markers (C-X-C chemokine receptor type 4-positive, stromal cell-derived factor-1α-positive) were lowest
in groups 1 and 2, higher in groups 3 and 4, and highest in group 5 (all P <0.05 for inter-group comparisons).
Conclusion: Combination therapy using CsA plus ADMSCs offers improved protection against acute IR kidney injury.* Correspondence: leu@mail.cgu.edu.tw; han.gung@msa.hinet.net
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Figure 1 Flow cytometry and microscopy analysis of rat adipose-derived mesenchymal stem cells and histopathological scoring of
renal injury. Flow cytometric analysis and microscopy findings of rat adipose-derived mesenchymal stem cells (ADMSCs) (n = 6) and
histopathological scoring of acute kidney ischemia–reperfusion (IR) injury at 72 hours after the IR procedure (n = 8). Upper panel: (A) Flow
cytometric results of rat ADMSCs and endothelial progenitor cells (EPC) on day 14 after cell culturing showed that CD90+ cells contributed the
highest population of stem cells (n = 6). (B) Spindle-shaped morphology of stem cells illustrated in the lower right corner (200×). (C) Percentage
of ADMSCs and EPC shown was the mean value of n = 6. Lower panel: (A) to (D), (G) to (K) H & E staining (200× in (A) to (E), and 400× in (G) to
(K)) of kidney sections in sham control, IR, IR + cyclosporine (CsA), IR + ADMSCs and IR + CsA + ADMSCs, showing significantly higher degree of
loss of brush border in renal tubules (yellow arrowheads), cast formation (green asterisk), tubular dilatation (blue asterisk), tubular necrosis (green
arrows), and dilatation of Bowman’s capsule (blue arrows) in the IR without treatment group than in other groups at 72 hours after IR procedure.
(F) *P <0.0001 vs. other groups with different symbols; † vs. ‡ vs. ¶ vs. §, all P <0.05 for inter-group comparisons. All statistical analyses were with
one-way analysis of variance followed by Bonferroni multiple comparison post-hoc test. Different symbols (*, †, ‡, ¶, §) among different groups
indicate significance (at 0.05 level). Scale bars in right lower corner = 50 μm.
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The kidney and its vital functions are vulnerable to da-
mage by a variety of disease processes given its frequent
exposure to reactive oxygen species (ROS) and toxic or-
ganic substances and its sensitivity to hemodynamic
instability such as following hypotensive shock [1-6]. Of
these processes [1-4,7], acute kidney injury caused by is-
chemic and/or ischemia–reperfusion (IR) injury [2,4,5]
remains one of the most important problems to be
solved for daily clinical practice [8-10]. Acute kidney in-
jury lacks effective management and yet is responsible
for high levels of inpatient morbidity and mortality
[1-3,8-10]. An effective and safe treatment for acute kid-
ney injury is therefore important and urgent for clini-
cians and scientists alike.
The underlying mechanism of acute organ IR injury
mainly involves an ROS burst during reperfusion of is-
chemic tissues that can trigger opening of the mitochon-
drial permeability transition (MPT) pore, mitochondrial
depolarization, decreased ATP synthesis and increased
ROS production [11-14]. ROS generation stimulates
pro-apoptotic mediators, inflammatory cytokines, fur-
ther oxidative stress and exacerbation of inflammation
[11-14]. The MPT pore comprises cyclophilin D, voltage-
dependent anion channels and adenine nucleotide trans-
locase [15-17]. Cyclosporine A (CsA), a cyclophilin D
inhibitor, is well recognized to reduce ROS generation
by inhibiting cyclophilin D action in the MPT pore
[18-21]. Indeed, CsA administration limited myocar-
dial infarct size [22] and protected organs against acute IR
injury [21,23].
Moreover, numerous experimental studies [24,25] and
clinical observational studies [26,27] have supported
mesenchymal stem cell (MSC) therapy being a safe and
promising modality for reversing ischemia-related or-
gan dysfunction [24-27] and improving clinical outcome
[26,27] mainly through angiogenic and paracrine effects.
Furthermore, recent data have revealed that MSCs have
intrinsic anti-inflammatory and immunomodulatory pro-
perties [28,29]. Importantly, MSC therapy reduced acuteorgan IR injury [5,6], including acute kidney IR injury
[5]. Interestingly, an in vitro study has previously shown
that human adipose tissue-derived MSCs facilitate the
immunosuppressive effect of CsA on T lymphocytes
through Jagged-1/Notch-related inhibition of NF-κB sig-
naling [30]. However, further preclinical experimental
study should be investigated to further confirm the
safety the efficacy of this combination therapy prior
to applying this strategic management for patients with
acute kidney IR injury.
Given the above properties of CsA and MSCs, this
study tested the hypothesis that CsA-supported adipose-
derived mesenchymal stem cell (ADMSC) therapy might
provide improved attenuation of acute kidney IR injury
in a rat model.
Methods
Ethics
All animal experimental procedures were approved by
the Institute of Animal Care and Use Committee at
Chang Gung Memorial Hospital – Kaohsiung Medical
Center (Affidavit of Approval of Animal Use Protocol
No. 2008121108) and were performed in accordance
with the Guide for the Care and Use of Laboratory Ani-
mals (NIH Publication No. 85–23, National Academy
Press, Washington, DC, USA, revised 1996).
Animal groups and isolation of adipose tissue for culture
of adipose-derived mesenchymal stem cells
Pathogen-free, adult male Sprague–Dawley rats (n = 40)
weighing 320 to350 g (Charles River Technology, Bio
LASCO Taiwan Co. Ltd, Taiwan) were randomized and
equally divided into: group 1, sham controls (n = 8);
group 2, acute kidney IR injury with DMEM medium
(500 μl) without fetal bovine serum, at 1, 6 and 24 hours
after the IR procedure (n = 8); group 3, acute kidney IR
injury + CsA (20.0 mg/kg intravenously at 1 and 24
hours after the IR procedure (n = 8); group 4, acute kid-
ney IR injury + syngeneic ADMSC (1.2 × 106) at 1, 6,
and 24 hours after the IR procedure (n = 8); and group
Table 1 Time courses for circulating levels of creatinine and BUN, and the urine protein:creatinine ratio
Variable Group 1 Group 2 Group 3 Group 4 Group 5 P value
At 0 hours
Serum creatinine (mg/dl) 0.21 ± 0.05 0.22 ± 0.03 0.19 ± 0.03 0.23 ± 0.04 0.19 ± 0.05 0.244
Serum BUN (mg/dl) 14.8 ± 2.1 16.3 ± 3.3 13.5 ± 1.1 17.1 ± 1.7 16.4 ± 2.2 0.062
Ratio of urine protein to creatinine 1.10 ± 0.17 1.14 ± 0.53 1.14 ± 0.32 1.35 ± 0.90 1.18 ± 0.34 0.924
At 24 hours
Serum creatinine (mg/dl) 0.27 ± 0.08* 3.28 ± 1.29† 1.72 ± 1.93‡ 1.55 ± 1.61‡ 1.6 ± 0.72‡ <0.001
Serum BUN (mg/dl) 16.6 ± 3.3* 86.7 ± 15.9† 67.8 ± 37.4‡ 68.0 ± 35.9‡ 68.0 ± 35.9‡ <0.001
Ratio of urine protein to creatinine 1.28 ± 0.49* 6.75 ± 2.92† 4.01 ± 0.80‡ 3.27 ± 0.33§ 2.73 ± 0.60¶ <0.001
At 72 hours
Serum creatinine (mg/dl) 0.44 ± 0.06* 3.58 ± 3.16† 1.21 ± 0.83‡ 1.27 ± 0.83‡ 0.82 ± 0.32§ <0.001
Serum BUN (mg/dl) 23.3 ± 2.2* 109 ± 89.7† 63.5 ± 37.4‡ 49.9 ± 29.5§ 47.7 ± 18.3§ <0.001
Ration of urine protein to creatinine 1.14 ± 0.60* 3.70 ± 2.82† 2.08 ± 2.06‡ 1.52 ± 0.34§ 1.19 ± 0.23¶ <0.001
Time courses of circulating levels of creatinine and blood urea nitrogen (BUN), and the ratio of urine protein to creatinine after acute kidney ischemia–reperfusion
procedure (n = 8 in each group). Data are expressed as mean ± standard deviation. Group 1 = sham control; group 2 = ischemia reperfusion (IR); group 3 = IR +
cyclosporine (CsA); group 4 = IR + adipose-derived mesenchymal stem cells (ADMSC); group 5 = IR + CsA + ADMSC. Statistical analysis in each group by analysis
of variance followed by Bonferroni multiple comparison post-hoc test. Symbols (*, †, ‡, §, ¶) indicate significance (at 0.05 level) by Bonferroni multiple-comparison
post-hoc test: † vs. ‡ vs. § vs. ¶, all P <0.05 for inter-group comparisons.
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(1.2 × 106) at 1, 6, and 24 hours after the IR procedure
(n = 8). CsA and syngeneic ADMSC dosages were cho-
sen according to our previous studies with minor mo-
difications [5,21,23]. Additionally, the choice of time
points for ADMSC administration at 1, 6, and 24 hours
after the IR procedure was based on our recent stu-
dy which demonstrated that ADMSC administration
at these time points after acute rat kidney IR injury
through penile venous transfusion markedly attenuated
acute IR-induced kidney injury [5,21,23]. Besides, theseTable 2 mRNA expression of apoptotic, inflammatory, oxidati
parenchyma after injury
Variable Group 1 Group 2 Group 3
Caspase 3 1* 1.24 ± 0.15† 0.91 ± 0
Bcl-2 1* 0.60 ± 0.06† 0.73 ± 0
TNF-α 1* 1.21 ± 0.09† 0.88 ± 0
MMP-9 1* 1.32 ± 0.1† 0.94 ± 0
RANTES 1* 1.30 ± 0.04† 1.03 ± 0
NOX-1 1* 1.30 ± 0.09† 1.07 ± 0
HO-1 1* 1.43 ± 0.10† 1.66 ± 0
NQO 1 1* 1.1 ± 0.07† 1.22 ± 0
IL-10 1* 1.66 ± 0.07† 1.60 ± 0
PGE-2 1* 0.82 ± 0.10† 1.05 ± 0
eNOS 1* 0.62 ± 0.04† 0.75 ± 0
Relative changes in mRNA expression of apoptotic, inflammatory, oxidative, antioxid
reperfusion injury (n = 8 in each group). Data expressed as mean ± standard deviat
matrix metalloproteinase; NOX, NAD(P)H oxidase; NQO, NAD(P)H quinone oxidoredu
and presumably secreted. Group 1 = sham control; group 2 = ischemia–reperfusion
mesenchymal stem cells (ADMSC); group 5 = IR + CsA + ADMSC. Statistical analysis
comparison post-hoc test. Symbols (*, †, ‡, §, ¶) indicate significance (at 0.05 level) b
for inter-group comparisons.time points were initially chosen in an attempt to mimic
the clinical scheduling of antibiotics (that is, cell therapy
is just like the drug to be used in our daily clinical prac-
tice) for patients with sepsis syndrome.
Isolation of adipose-derived mesenchymal stem cells from
Sprague–Dawley rats
Rats in groups 4 and 5 were anesthetized with inhala-
tional 2% isoflurane 14 days before induction of acute
kidney IR injury for harvest of peri-epididymal adipose
tissue, as we reported previously [5,6]. In detail, theve, antioxidant, and anti-inflammatory mediators in renal
Group 4 Group 5 P value
.09‡ 0.88 ± 0.07‡ 0.6 ± 0.06§ <0.0001
.06‡ 0.77 ± 0.06‡ 0.94 ± 0.09§ <0.0009
.07‡ 0.84 ± 0.04‡ 0.56 ± 0.07§ <0.0001
.08‡ 0.92 ± 0.04‡ 0.69 ±0.05§ <0.0001
.04‡ 1.08 ± 0.06‡ 0.84 ± 0.07§ <0.003
.05‡ 1.03 ± 0.04‡ 0.89 ± 0.05§ <0.007
.09‡ 1.92 ± 0.11§ 2.32 ± 0.11¶ <0.0001
.09‡ 1.32 ± 0.04§ 1.44 ± 0.10¶ <0.0001
.11‡ 2.09 ± 0.06§ 2.75 ± 0.11¶ <0.0001
.07‡ 1.17 ± 0.05§ 1.29 ± 0.07¶ <0.0001
.05‡ 0.89 ± 0.05§ 1.11 ± 0.04* <0.0001
ant, and anti-inflammatory mediators in renal parenchyma after ischemia–
ion. eNOS, endothelial nitric oxide synthase; HO-1, heme oxygenase 1; MMP,
ctase; PGE2, prostaglandin E2; RANTES, regulated and normal T-cell expressed
(IR); group 3 = IR + cyclosporine (CsA); group 4 = IR + adipose-derived
in each group by analysis of variance followed by Bonferroni multiple
y Bonferroni multiple-comparison post-hoc test: † vs. ‡ vs. § vs. ¶, all P <0.05
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dissected and excised. Then 200 to 300 μl sterile saline
was added to every 0.5 g tissue to prevent dehydration.
The tissue was cut into <1 mm3 size pieces using sharp,
sterile surgical scissors. Sterile saline (37°C) was added
to the homogenized adipose tissue in a ratio of 3:1 (saline:
adipose tissue), followed by the addition of stock collage-
nase solution to a final concentration of 0.5 units/ml. The
tubes with the contents were placed and secured on aFigure 2 Immunofluorescent staining for inflammatory cells and enzym
(IF) staining for inflammatory cells and enzymatic analysis of superoxide dism
procedure (n = 8). (A) to (E) High-power field (HPF) IF microscopic findings (2
the five groups. Scale bars in right lower corner = 50 μm. (F) *P <0.0001 vs. o
inter-group comparisons. (G) Analytical result of SOD activity in renal parench
with different symbols; † vs. ‡ vs. ¶ vs. §, all P <0.05 for inter-group comparis
followed by Bonferroni multiple comparison post-hoc test. Different symbols
adipose-derived mesenchymal stem cell; CsA, cyclosporine A.Thermaline shaker and incubated with constant agitation
for 60 ± 15 minutes at 37°C. After 40 minutes of incuba-
tion, the content was triturated with a 25 ml pipette for 2
to 3 minutes. The cells obtained were placed back on the
rocker for incubation. The contents of the flask were
transferred to 50 ml tubes after digestion, followed by cen-
trifugation at 600×g for 5 minutes at room temperature.
The fat layer and saline supernatant from the tube were
poured out gently in one smooth motion or were removedatic analysis of superoxide dismutase activity. Immunofluorescent
utase (SOD) activity at 72 hours after the ischemia–reperfusion (IR)
00×) showing the number of CD68+ cell infiltration (white arrows) in
ther groups with different symbols; † vs. ‡ vs. ¶ vs. §, all P <0.05 for
yma at 72 hours after the IR procedure. *P <0.0001 vs. other groups
ons. All statistical analyses were with one-way analysis of variance
among different groups indicate significance (at 0.05 level). ADMSC,
Figure 3 (See legend on next page.)
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Figure 3 Immunohistochemical staining for renal expressions of antioxidative markers at 72 hours after ischemia–reperfusion
procedure. (A) to (E) Microscopic findings of immunohistochemical (IHC) stain (n =8, 200×) for glutathione reductase (GR)-positive cells (brown)
in renal parenchyma of five groups. Scale bars in right lower corner = 50 μm. (F) *P <0.001 vs. other groups with different symbols; † vs. ‡ vs. ¶,
all P <0.05 for inter-group comparisons. (G) to (K) Microscopic findings of IHC stain (200×) for glutathione peroxidase (GPx)-positive cells (brown)
renal parenchyma of five groups. Scale bars in right lower corner = 50 μm. (L) *P <0.001 vs. other groups with different symbols; † vs. ‡ vs. ¶, all
P <0.05 for inter-group comparisons. All statistical analyses performed using one-way analysis of variance followed by Bonferroni multiple
comparison post-hoc test. Different symbols (*, †, ‡, ¶) among different groups indicate significance (at 0.05 level). ADMSC, adipose-derived
mesenchymal stem cell; CsA, cyclosporine A.
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resuspended in 40 ml saline and then centrifuged again at
600×g for 5 minutes at room temperature. After being
resuspended again in 5 ml saline, the cell suspension was
filtered through a 100 μm filter into a 50 ml conical tube
to which 2 ml saline was added to rinse the remaining
cells through the filter. The flow-through was pipetted to
a 40 μm filter into a new 50 ml conical tube. The tubes
were centrifuged for a third time at 600×g for 5 minutes
at room temperature. The cells were resuspended in
saline.
Isolated ADMSCs were cultured in a 100 mm diame-
ter dish with 10 ml DMEM culture medium containing
10% fetal bovine serum for 14 days (see Figure 1B for
microscopy). Flow cytometric analysis was performed to
identify cellular characteristics after cell-labeling with
appropriate antibodies on day 14 of cell cultivation 30
minutes prior to implantation (Figure 1A,B,C).
ADMSC labeling and acute kidney ischemia–reperfusion
injury protocol
On day 14, CM-Dil (Vybrant™ Dil cell-labeling solution,
50 μg/ml; Molecular Probes, Inc., Carlsbad, CA, USA) was
added to the culture medium 30 minutes before the acute
kidney IR procedure for ADMSC labeling as reported pre-
viously [5]. After ADMSC labeling, all animals were anes-
thetized by inhalational 2.0% isoflurane, and placed supine
on a warming pad at 37°C for midline laparotomies; left
nephrectomies were performed in groups 2, 3, 4 and 5 but
sham-operated rats (group 1) received laparotomy alone.
Acute right kidney IR injury was then conducted in all
animals except sham controls by clamping the right renal
pedicle for 1 hour using nontraumatic vascular clips be-
fore reperfusion for 72 hours.
Group 2 animals received an intravenous injection of
500 μl DMEM medium only 1 hour after the ischemia
procedure, followed by intravenous injections of 500 μl
DMEM medium at 6 and 24 hours after the IR proce-
dure through the penile vein. Group 4 and 5 animals
underwent the same protocol, except an equal volume
of DMEM medium (500 ml) with syngeneic ADMSCs
(1.2 × 106) was administered at each time point instead
of pure culture medium. All animals were sacrificed
72 hours after the IR procedure.Measurement of renal function before and after
ischemia–reperfusion procedure
Blood samples that were collected before and after (at 24
and 72 hours) the IR procedure before their sacrifice were
then stored at −80°C until analyses of serum blood urea
nitrogen (BUN), urine protein and urine creatinine were
performed at the end of the experiment for all animals.
The concentrations of these biomarkers were assessed in
duplicate with a commercially available assay kit (BioAssay
Systems, Hayward, CA, USA). Intra-individual variability
in creatinine and BUN level were assessed in each group.
The mean intra-assay coefficients of variance for creatin-
ine and BUN were all <4.0%, respectively.
Collection of 24-hour urine before and after (on days 1
and 3) ischemia–reperfusion procedure
Twenty-four-hour urine was collected in all animals
prior to the IR procedure and at 24 and 72 hours after
the IR procedure before their sacrifice to determine the
daily urine volume and to measure the ratio of urine
protein to urine creatinine excretion.
Histopathology scoring at 72 hours after the
ischemia–reperfusion procedure
Histopathology scoring was determined in blinded fashion
as reported previously [5,31]. Briefly, the right kidney
specimens from all animals were fixed in 10% buffered
formalin, embedded in paraffin, sectioned at 5 μm and
stained (H & E) for light microscopy. The score reflected
the grading of tubular necrosis, loss of brush border, cast
formation and tubular dilatation in 10 randomly chosen,
nonoverlapping fields (200×) as follows: 0, none; 1, ≤10%;
2, 11 to 25%; 3, 26 to 45%; 4, 46 to 75%; and 5, ≥76%.
Immunofluorescent and immunohistochemical studies
The immunofluorescent (IF) and immunohistochemical
(IHC) methodologies used in this study have recently
been described in detail [5]. Briefly, CM-Dil-positive
ADMSCs, which were engrafted in the right renal paren-
chyma, were determined using the IF staining methodology
that we also used for the examination of heme oxygenase
(HO)-1-positive cells and CD68+ cells (an indicator of
macrophage) using respective primary antibodies. Moreover,
our IHC labeling technique was adopted to identify
Figure 4 (See legend on next page.)
Chen et al. Stem Cell Research & Therapy 2013, 4:62 Page 8 of 21
http://stemcellres.com/content/4/3/62
(See figure on previous page.)
Figure 4 Immunofluorescent staining for renal heme oxygenase-1 antioxidant and alpha smooth muscle actin expressions.
Immunofluorescent (IF) staining for renal heme oxygenase (HO)-1 antioxidant and alpha smooth muscle actin (α-SMA) expressions at 72 hours
after ischemia–reperfusion (IR) (n = 8). (A) to (E) Microscopic findings of IF staining (200×) for number of HO-1+ cells (white arrows) in renal
parenchyma of five groups. Scale bars in right lower corner = 50 μm. (F) *P <0.0001 vs. other groups with different symbols; † vs. ‡ vs. ¶ vs. §,
all P <0.05 for inter-group comparisons. (G) to (K) Microscopic (100×) findings of α-SMA staining for the number of small vessels (defined as
diameter <25 μm; red arrows) among five groups. (L) *P <0.001 vs. other groups with different symbols; † vs. ‡ vs. ¶, all P <0.05 for inter-group
comparisons. Scale bars at right lower corner = 100 μm (100×). All statistical analyses performed using one-way analysis of variance followed by
Bonferroni multiple comparison post-hoc test. Different symbols (*, †, ‡, ¶, §) among different groups indicate significance at the 0.05 level.
ADMSC, adipose-derived mesenchymal stem cell; CsA, cyclosporine A.
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(GR)-positive and proliferating cell nuclear antigen-positive
cells using respective primary antibodies based on our recent
study [32]. Irrelevant antibodies were used as controls in the
current study. Additionally, an IHC-based scoring system
was conducted in blinded fashion for semiquantitative ana-
lyses of GR and GPx as a percentage of positive cells. Scoring
of positively-stained cells for GR and GPx was as follows: 0,
no stain; 1, <15%; 2, 15 to 25%; 3, 25 to 50%; 4, 50 to 75%; 5,
>75 to 100% per high-power field; 200×).
Western blot analysis of right kidney specimens
Our methods were previously detailed in our recent reports
[5-7,21]. mAbs against intercellular adhesion molecule-1
(1:2000; Abcam, Cambridge, MA, USA), NAD(P)H quin-
one oxidoreductase (NQO)-1 (1:1,000; Abcam, Cambridge,
MA, USA), HO-1 (1:250; Abcam), and polyclonal anti-
bodies against TNFα (1:1,000; Cell Signaling, Danvers, MA,
USA), NF-κB (1:250; Abcam, Cambridge, MA, USA),
platelet-derived growth factor (1:500; Abcam, Cambridge,
MA, USA), NADPH oxidase (NOX)-1 (1:1,500; Sigma, St.
Louis, MO, USA), NOX-2 (1:500; Sigma, St. Louis, MO,
USA), Bax (1:1,000; Abcam, Cambridge, MA, USA),
caspase 3 (1:1,000; Cell Signaling, Danvers, MA, USA), poly
(ADP-ribose) polymerase (PARP) (1:1,000; Cell Signaling,
Danvers, MA, USA), Bcl-2 (1:250; Abcam, Cambridge,
MA, USA), cytosolic cytochrome C (1:2,000; BD, San Jose,
CA, USA), mitochondrial cytochrome C (1:2,000; BD) and
endothelial nitric oxide synthase (eNOS) (1:1,000; Abcam,
Cambridge, MA, USA) were used. Signals were detected
with horseradish peroxidase-conjugated goat anti-mouse,
goat anti-rat, or goat anti-rabbit IgG.
The Oxyblot Oxidized Protein Detection Kit was pur-
chased from Chemicon (S7150, Billerica, MA, USA).
The procedure was the same as we reported previously
[5,6,21]. A standard control was loaded on each gel.
Real-time quantitative PCR analysis
The mRNA expressions of caspase 3, Bcl-2, matrix metal-
loproteinase-9, TNFα, NF-κB, RANTES, NOX-1, NOX-2,
HO-1, NQO-1, IL-10, prostaglandin E2 and eNOS in each
of the five groups of animals were analyzed with quantita-
tive real-time PCR and compared. Technical details were
according to our previous reports [5-7,21].Superoxide dismutase assay
After weighing, the right kidney was sliced, homoge-
nized in lysis buffer (100 μM Tris–HCl, pH 7.4
containing 0.5% Triton, 5 mM β-mercaptoethanol,
0.1 mg/ml phenylmethylsulfonyl fluoride) with the
Dounce homogenizer and then centrifuged at 14,000×g
for 5 minutes to remove tissue debris. The supernatant
was collected and the protein concentration determined
with the BCA protein assay kit (Pierce, Rockford, IL,
USA). The final total protein concentration was ad-
justed to 20 mg/ml. To measure superoxide dismutase
(SOD) activity, 20 μl (containing 400 μg protein) was
applied for enzymatic reaction with a commercial SOD
assay kit (#K335-100; BioVision, Mountain View, CA,
USA). Sample preparation and calculation of SOD activ-
ity were performed according to the manufacturer’s
instructions.
Statistical analysis
Quantitative data are expressed as the mean ± standard
deviation. Statistical analyses were performed using SAS
statistical software for Windows version 8.2 (SAS Institute,
Cary, NC, USA) to conduct analysis of variance followed
by Bonferroni multiple-comparison post-hoc test. P <0.05
was considered statistically significant.
Results
Time courses of circulating levels of creatinine and blood
urea nitrogen, and the ratio of urine protein to creatinine
after acute kidney IR procedure
Three time points (before, 24 hours after and 72 hours
after the acute kidney IR procedure) were chosen to
evaluate serial changes in serum levels of creatinine and
BUN (Table 1). Creatinine and BUN levels did not differ
between the five groups prior to the IR procedure. How-
ever, both BUN and creatinine levels were significantly
higher in IR (group 2) than in normal controls (group 1),
IR + CsA (group 3), IR + ADMSC (group 4) and IR +
CsA-ADMSC (group 5), significantly higher in groups 3, 4
and 5 than in group 1, but not different amongst groups 3,
4 and 5 at 24 hours after the IR procedure (Table 1). By 72
hours after the IR procedure, serum creatinine was highest
in group 2 and lowest in group 1, significantly higher
in groups 3 and 4 than in group 5, but not different
Figure 5 (See legend on next page.)
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Figure 5 Engraftment of adipose-derived mesenchymal stem cells in renal tissue at 72 hours after ischemia–reperfusion. (A) to (E)
Identification of double-stained adipose-derived mesenchymal stem cells (ADMSCs) (Dil dye + CXCR4+ cells; red arrows) and single stain for
CXCR4+ cells (white arrows) (400×) in peri-tubular and interstitial areas of kidney 72 hours post ischemia–reperfusion (IR) procedure among five
groups (n = 8). (D), (E) Merged image from double-staining (Dil + CXCR4) showing cellular elements of mixed green and yellow under higher
magnifications ((B) and (D) are magnified images of (A) and (C), respectively), indicating implanted CXCR4+ cells in lung parenchyma. DAPI
counter-staining for nuclei (blue). Scale bars at right lower corner = 20 μm. (F) *P <0.0001 vs. other groups with different symbols; † vs. ‡ vs. ¶
vs. §, all P <0.05 for inter-group comparisons. (G) to (K) Identification of single stain for stromal cell-derived factor (SDF)-1α+ cells (red color; white
arrows) (400×) in peri-tubular area and interstitial area of kidney 72 hours post IR procedure among five groups. DAPI counter-staining for nuclei
(blue). Scale bars at right lower corner = 20 μm. (L) *P <0.0001 vs. other groups with different symbols; † vs. ‡ vs. ¶ vs. §, all P <0.05 for inter-
group comparisons. All statistical analyses performed using one-way analysis of variance followed by Bonferroni multiple comparison post-hoc
test. Different symbols (*, †, ‡, ¶, §) among different groups indicate significance at the 0.05 level. CsA, cyclosporine A.
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was lowest in group 1 and highest in group 2, signifi-
cantly higher in group 3 than in groups 4 and 5, but
similar in groups 4 and 5 (Table 1). These findings
implicated that either CsA or ADMSC therapy signi-
ficantly protected, and combined therapy with CsA-
ADMSC more significantly protected, renal function
after IR injury.
The ratio of urine protein to urine creatinine was simi-
lar in the five groups prior to the IR procedure. How-
ever, at 24 and 72 hours after IR, this parameter was
highest in group 2 and lowest in group 1, significantly
higher in group 3 than in groups 4 and 5, and signifi-
cantly higher in group 4 than group 5 (Table 1).
Changes in mRNA expressions of apoptotic,
inflammatory, oxidative, antioxidant, and anti-
inflammatory mediators in renal parenchyma
From tissues harvested at 72 hours post IR injury, the
mRNA expression of caspase 3, an index of apoptosis,
was highest in group 2 and lowest in group 1, signifi-
cantly higher in groups 3 and 4 than in group 5, but
similar in groups 3 and 4. Conversely, the pattern of
mRNA expression of Bcl-2, an index of anti-apoptosis,
was opposite to that of Bax mRNA expression in the five
groups (Table 2).
From tissues harvested at 72 hours post IR injury, the
mRNA expression of TNFα, matrix metalloproteinase-9
and RANTES, three indicators of inflammation, were
highest in group 2 and lowest in group 1, significantly
higher in groups 3 and 4 than in group 5, but not sig-
nificantly different between groups 3 and 4; this pattern
was identical for the mRNA expressions of NOX-1 and
NOX-2, two oxidative stress biomarkers. Conversely, the
patterns of mRNA expressions of HO-1 and NQO 1,
two antioxidant/antioxidative stress biomarkers, were
opposite to those of NOX-1 and NOX-2 in the five
groups (Table 2).
From tissues harvested at 72 hours post IR injury, the
mRNA expression of IL-10, an anti-inflammatory bio-
marker, was lowest in group 1 and highest in group 5,
significantly higher in groups 3 and 4 than in group 2,and significantly higher in group 4 than in group 3. Ad-
ditionally, the mRNA expression of prostaglandin E2, an
anti-inflammatory mediator, was lowest in group 2 and
highest in group 5, significantly higher in group 4 than
in groups 1 and 3, but similar in groups 1 and 3. Fur-
thermore, the mRNA expression of eNOS, an index of
anti-inflammatory mediator/endothelial cell integrity,
was lowest in group 2 and highest in groups 1 and 5, sig-
nificantly higher in group 4 than in group 3, but similar
in groups 1 and 5 (Table 2).
Flow cytometric analysis and histopathology of kidney
The upper panel of Figure 1 (Figure 1A,B,C) illustrated
the flow cytometric results of rat ADMSCs and endothe-
lial progenitor cells (EPCs) on day 14 after cell culturing.
The results showed that CD90+ cells contributed the
highest population of stem cells.
To determine the effects of CsA, ADMSC transplan-
tation and a combination of these treatments on IR-
induced renal injury, a histological scoring system based
on the typical microscopic features of acute tubular
damage (including extensive tubular necrosis and dilata-
tion, cast formation and loss of brush border) was adop-
ted (Figure 1, lower panel). At 72 hours after the IR
procedure, this injury score was highest in group 2, sig-
nificantly higher in group 3 than in groups 1, 4 and 5,
significantly higher in group 4 than in groups 1 and 5,
and significantly higher in group 5 than in group 1.
These findings suggest that CsA monotherapy signi-
ficantly protected the kidney from IR damage, but that
ADMSC therapy offered significantly more protection
than CsA. Combination therapy using CsA plus ADMSCs,
however, offered significantly better protection than either
of these monotherapies.
Infiltrated CD68+ cells and superoxide dismutase activity
in kidney
From tissues harvested at 72 hours post IR injury, the
number of CD68+ cells (that is, macrophages), an index
of inflammation, was highest in group 2 and lowest in
group 1, significantly higher in groups 3 and 4 than in
group 5, and significantly higher in group 3 than in
Figure 6 (See legend on next page.)
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Figure 6 Immunofluorescent stains for presence of CD31+ and vWF+ cells in renal parenchyma after ischemia–reperfusion.
Immunofluorescent (IF) stains for presence of CD31+ and von Willebrand Factor (vWF)+ cells in renal parenchyma at 72 hours after ischemia–
reperfusion (IR) (n = 8). (A) to (E) IF staining (200×) of CD31+ cells (white) in renal parenchyma. Notably fewer CD31+ cells in the IR group (B)
than in other groups (A, C, D, E). (D), (E) Merged image from double-staining (DiI + CD31) showing cellular elements of mixed red and yellow
(red arrows) under higher magnifications ((B) and (D) are magnified images of (A) and (C), respectively), indicating implanted numerous doubly-
stained cells (CD31+) in peri-tubular and interstitial areas. DAPI counter-staining for nuclei (blue). Scale bars at right lower corner = 50 μm. F)
*P <0.0001 vs. other groups with different symbols; † vs. ‡ vs. ¶ vs. §, all P <0.05 for inter-group comparisons. (G) to (K) IF staining (200×) of vWF+
cells (white) in renal parenchyma. Notably fewer vWF+ cells in the IR group (H) than in other groups (G, I, J, K). (K) Merged image from double-
staining (DiI + vWF) showing cellular elements of mixed red and yellow (red arrows) under higher magnifications ((F) and (H) are magnified
images of (E) and (G), respectively), indicating implanted doubly-stained cells (vWF+) in peri-tubular and interstitial areas. DAPI counter-staining
for nuclei (blue). Scale bars at right lower corner = 50 μm. (L) *P <0.0001 vs. other groups with different symbols; † vs. ‡ vs. ¶ vs. §, all P <0.05 for
inter-group comparisons. All statistical analyses performed using one-way analysis of variance followed by Bonferroni multiple comparison
post-hoc test. Different symbols (*, †, ‡, ¶, §) among different groups indicate significance at the 0.05 level. ADMSC, adipose-derived mesenchymal
stem cells; CsA, cyclosporine A.
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of oxidative stress, showed a similar pattern except for a
significant reverse relationship between groups 3 and 4
(Figure 2).
Expressions of antioxidant activity and vascular density in
kidney
From tissues harvested at 72 hours post IR injury,
IHC staining demonstrated that the expressions of GR
(Figure 3A to F) and GPx (Figure 3G to L), two oxidore-
ductase enzymes, were highest in group 5 and lowest in
group 1, significantly higher in groups 3 and 4 than in
group 2, but similar in groups 3 and 4. Additionally, IF
staining revealed that the number of HO-1-positive cells,
another indicator of oxidoreductase enzyme, exhibited
an identical pattern to GR and GPx IHC staining in the
five groups (Figure 4A to F).
Staining for α-smooth muscle actin showed that the
number of small vessels in kidney parenchyma was
highest in group 1 and lowest in group 2, significantly
higher in group 5 than in groups 3 and 4, but similar in
groups 3 and 4 (Figure 4G to L).
Angiogenesis biomarkers of kidney
From tissues harvested at 72 hours post IR injury, the
number of CXCR4+ cells (Figure 5A to F) and SDF-1α+
cells (Figure 5G to L), two indices of EPC surface mar-
kers, were highest in group 5, lowest in group 1, signi-
ficantly lower in group 2 than in groups 3 and 4, and
significantly lower in group 3 than in group 4. Addi-
tionally, CD31+ cells (Figure 6A to F) and vWF+ cells
(Figure 6G to L), two indicators of endothelial cell sur-
face markers, were highest in group 5 and lowest in
group 2, significantly higher in group 1 than in groups 3
and 4, and significantly higher in group 4 than in group 3.
Molecular-cellular damaged biomarkers in kidney
From tissues harvested at 72 hours post IR injury, IF stain-
ing showed that expression of γH2AX-positively stainedcells, an index of DNA damage, was highest in group 2
and lowest in group 1, significantly higher in groups 3 and
4 than in group 5, but similar in groups 3 and 4 (Figure 7A
to F). IHC staining demonstrated that the number of pro-
liferating cell nuclear antigen-positively stained cells, an
indicator of damaged DNA and replication, exhibited an
identical pattern to that of γH2AX-positively stained cells
in the five groups (Figure 7G to L).
Protein expressions of inflammatory, reactive oxygen
species and cytochrome C biomarkers in kidney
To confirm further the expression of inflammatory mar-
kers and ROS in IR-injured renal parenchyma, western
blot was performed from tissues harvested at 72 hours
post IR injury. Results indicated that protein expressions
of TNFα, NF-κB, intercellular adhesion molecule-1 and
platelet-derived growth factor, four inflammatory bio-
markers, were highest in group 2 and lowest in group 1,
significantly higher in groups 3 and 4 than in group 5,
but similar in groups 3 and 4 (Figure 8A to D). Protein
expression of NOX-1, an index of ROS, showed an iden-
tical pattern (Figure 8E). Protein expression of NOX-2,
another index of ROS, was highest in group 2, lowest in
group 1, significantly higher in groups 3 and 4 than in
group 5, and significantly higher in group 3 than in
group 4 (Figure 8F).
As expected, at 72 hours after the IR procedure, the
protein expressions of mitochondrial Bax (Figure 8G)
and cleaved PARP (Figure 8I), two indices of apoptotic
mediators, were higher in group 2 and lowest in group
1, significantly higher in groups 3 and 4 than in group 5,
but similar in groups 3 and 4. Protein expression of
cleaved caspase 3 (Figure 8H), another indicator of apop-
tosis, showed an identical pattern to Bax and PARP in
groups 1, 2, 3 and 5; this parameter was also significantly
higher in group 3 than in group 4.
From tissues harvested at 72 hours post IR injury, total
mitochondrial cytochrome C protein expression was lo-
west in group 2 and highest in group 1, significantly
Figure 7 (See legend on next page.)
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Figure 7 Immunofluorescent and immunohistochemical stains of DNA damage cellular markers in renal parenchyma after ischemia–
reperfusion. Immunofluorescent (IF) and immunohistochemical (IHC) stains of DNA damage cellular markers in renal parenchyma at 72 hours
after ischemia–reperfusion (IR) (n = 8). (A) to (E) Microscopic findings of IF stain (400×) for γH2AX+ cells (white arrows) in renal parenchyma of
five groups. DAPI counter-staining for nuclei (blue). Scale bars in right lower corner = 20 μm. (F) *P <0.0001 vs. other groups with different
symbols; † vs. ‡ vs. ¶, all P <0.05 for inter-group comparisons. (G) to (K) Microscopic findings of IF stain (200×) for proliferating cell nuclear
antigen-positive (PCNA+) cells (red arrows) in renal parenchyma of five groups. DAPI counter-staining for nuclei (blue). Scale bars in right lower
corner = 50 μm. (L) *P <0.0001 vs. other groups with different symbols; † vs. ‡ vs. ¶, all P <0.05 for inter-group comparisons. All statistical analyses
performed using one-way analysis of variance followed by Bonferroni multiple comparison post-hoc test. Different symbols (*, †, ‡, ¶) among
different groups indicate significance at the 0.05 level. ADMSC, adipose-derived mesenchymal stem cells; CsA, cyclosporine A.
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in groups 3 and 4 (Figure 8K). The total amount of cy-
tosolic cytochrome C protein expression showed a re-
verse pattern to mitochondrial cytochrome C in the five
groups. These findings indicate that the expression of
cytochrome C, an index of energy supply and storage in
mitochondria, was preserved by either CsA or ADMSC
monotherapy but better preserved by combination the-
rapy using CsA and ADMSC (Figure 8J). The highest
level of cytosolic cytochrome C in group 2 also suggests
significant mitochondrial damage with cytochrome C re-
lease into the cytosol in the ischemic kidney.
Protein expressions of oxidative stress and antioxidant
mediators in kidney
From tissues harvested at 72 hours post IR injury, the
expression of oxidized protein, an index of oxidative
stress, was highest in group 2 and lowest in group 1, sig-
nificantly higher in groups 3 and 4 than in group 5, but
similar in groups 3 and 4 (Figure 9A,B). Additionally,
the protein expressions of HO-1 (Figure 9C) and NQO
1 (Figure 9D), two indicators of antioxidants, was lowest
in group 1 and highest in group 5, significantly lower in
group 2 than in groups 3 and 4, and significantly lower
in group 3 than in group 4. The protein expression of
eNOS, an indicator of anti-inflammation/integrity of
endothelial function, was lowest in group 2 and highest
in group 1, significantly higher in group 5 than in groups
3 and 4, and significantly higher in group 4 than in
group 3 (Figure 9E).
Discussion
The results of our study demonstrated that systemic
combination therapy using CsA and ADMSC was supe-
rior to either monotherapy alone at significantly de-
creasing IR-induced acute kidney injury by inhibiting
IR-triggered macrophage recruitment, DNA damage, in-
flammation, oxidative stress and ROS generation, and by
activating the cellular apoptotic signaling pathway and
enhancing angiogenic and antioxidant factors. These
findings have important clinical relevance in that CsA
and ADMSC combination therapy may quickly serve as
a new and promising management strategy against acutekidney injury without ethical barriers, especially in pa-
tients rejecting renal transplants.
The most important finding in the present study was
that the serum levels of BUN and creatinine, two es-
sential indices of renal function, were substantially in-
creased in acute kidney IR animals compared with sham
controls. Additionally, the ratio of urine protein to
creatinine, a useful indicator of renal functional im-
pairment, was remarkably increased in acute kidney IR
animals compared with sham controls. Furthermore,
histopathological renal injury scores were significantly
higher in kidney IR animals than in sham controls, but
were significantly improved by either CsA or ADMSC
monotherapy. Of importance, this study is the first to
demonstrate that combination therapy using CsA and
ADMSC was superior to either monotherapy alone at re-
versing impaired renal function and protecting the kid-
ney from acute IR injury.
Previous studies have clearly shown that acute inflam-
mation played an essential role in organ injury in the
setting of IR [5,6]. The present study showed that infla-
mmatory mediators (that is, matrix metalloproteinase-9,
TNFα, RANTES, NF-κB, intercellular adhesion mole-
cule-1, platelet-derived growth factor, CD68+ cells, SOD
activity) were markedly higher in animals that under-
went the IR procedure than in animals that did not,
consistent with other studies [5,6]. The role of the im-
munosuppressant/anti-inflammatory CsA has been well
investigated [21,23]. Growing data have demonstrated
that ADMSCs also have a distinctive capacity to sup-
press inflammation [5,6,28]. In the present study, the
expressions of these inflammatory biomarkers were re-
markably reduced equally by either CsA or ADMSC
monotherapy, corroborating the findings of others
[5,6,21,23,28]. Of particular importance, however, was
that combination therapy using CsA and ADMSC pro-
vided a significantly more profound effect at reducing
inflammatory mediators. This finding lends at least some
explanation to why kidney IR injury was attenuated by
either monotherapy alone and yet was further attenuated
by the co-treatment regimen.
Organ damage from acute IR has been shown princi-
pally to result from the ROS burst during reperfusion of
Figure 8 (See legend on next page.)
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Figure 8 Protein expression of inflammatory, reactive oxygen species, apoptotic and cytochrome C biomarkers in kidney.
Changes in protein expression of inflammatory, reactive oxygen species (ROS), apoptotic and cytochrome C biomarkers in kidney at 72
hours after ischemia–reperfusion (IR) (n = 8). Protein expressions of TNFα (A), NF-κB (B), intercellular adhesion molecule (ICAM)-1 (C) and
platelet-derived growth factor (PDGF) (D) were highest in the IR group and lowest in the sham control group, significantly higher in IR +
cyclosporine A (CsA) and adipose-derived mesenchymal stem cell (ADMSC) groups than in the IR + CsA–ADMSC group. *P <0.001 vs.
other groups with different symbols; * vs. † vs. ‡ vs. §, all P <0.05 for inter-group comparisons. Protein expressions of NADPH oxidase
(NOX)-1 (E) and NOX-2 (F) were highest in the IR group and lowest in the sham control group, significantly higher in IR + CsA and
ADMSC groups than in the IR + CsA–ADMSC group. *P <0.001 vs. other groups with different symbols; † vs. ‡ vs. § vs. ¶, all P <0.05 for
inter-group comparisons. Protein expressions of mitochondrial Bax (G), cleaved caspase 3 (H) and cleaved poly(ADP-ribose) polymerase
(PARP) (I) were highest in the IR group and lowest in the sham control group, significantly higher in IR + CsA and ADMSC groups than
in IR + CsA–ADMSC group. For Bax and PARP: *P <0.001 vs. other groups with different symbols; † vs. ‡ vs. §, all P <0.05 for inter-group
comparisons. The protein expression of cytosolic cytochrome C (J) was notably higher whereas mitochondrial cytochrome C (K) was
markedly lower in the IR group than in other groups. *P <0.001 vs. other groups with different symbols; † vs. ‡ vs. §, all P <0.05 for
inter-group comparisons. All statistical analyses performed using one-way analysis of variance followed by Bonferroni multiple comparison
post-hoc test.
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pore [11-14]. The generation of ROS, in turn, con-
tributes to the production of apoptotic mediators, in-
flammatory cytokines and oxidative stress [11-14]. One
important finding in the current study was that, com-
pared with normal controls, the protein expressions of
oxidative stress (that is, oxidized protein), ROS (NOX-1,
NOX-2) and enzymatic analysis of SOD activity were
significantly enhanced in animals after acute kidney
IR without treatment. Additionally, the apoptotic bio-
markers (Bax, caspase 3, PARP) and cellular–molecular
damage biomarker (γH2AX) were significantly increased
in kidney IR animals compared with sham controls. The
findings of the present study therefore strengthen the
findings of previous studies [11-14]. These parameters
were significantly ameliorated by CsA or ADMSC mo-
notherapy, lending support to previous studies that have
also shown CsA or ADMSC had anti-apoptotic and anti-
ROS/antioxidative stress capacities [5,6,21,23]. Distinc-
tive to the current study was that co-treatment using
CsA and ADMSC was superior to either monotherapy
alone at ameliorating these mediators. These findings
again partially explain why acute kidney IR injury was
reduced further by our CsA and ADMSC co-treatment
strategy. Surprisingly, the number of proliferating cell
nuclear antigen-positive cells in the kidney, a sign of re-
pair and regeneration, was found to be notably increased
in the IR animals without treatment compared with
those animals with treatment. We suggest that this could
be explained as a result of a rigorous and struggling res-
ponse to the IR injury.
In contrast to the findings of inflammatory, oxidative
stress and ROS biomarkers, the antioxidant and anti-
inflammatory biomarkers (HO-1, NQO 1, GPx, GR,
IL-10, prostaglandin E2, eNOS) were notably lower in
IR animals that were significantly reversed by either
CsA or ADMSC treatment. The impact of ADMSC or
CsA on enhancing the generation of antioxidant/anti-
inflammatory mediators and hence protecting againstorgan damage from ischemia or IR have been empha-
sized by previous reports [5,6,21,23-25]; in this way, our
findings were consistent with those of others. However,
we demonstrated that combination therapy with CsA and
ADMSCs contributed enhanced generation of these
advantageous biomarkers, lending further explanation
to why kidney IR injury was diminished more by co-
treatment with CsA and ADMSC than mono-treatment
with either.
Of interest, IF staining revealed significantly lower
numbers of endothelial surface markers (that is, CD31+
and vWF+ cells) and EPC surface markers (that is,
CXCR4+, SDF-1α+ cells) in IR animals being significantly
preserved by CsA therapy, but being preserved signifi-
cantly better by ADMSC therapy. One previous study
has also demonstrated that autologous transfusion of
ADMSCs to animals with acute IR-injured kidney en-
hanced angiogenesis in IR kidney tissue [5], supporting
our findings. More importantly, combination therapy
with CsA and ADMSC not only contributed to an in-
crease in the numbers of endothelial cell and EPC sur-
face markers but also to an increased number of small
vessels (representing angiogenesis) in IR-injured kidney.
These findings lend further explanation to why renal
function was better preserved and kidney injury scores
were further reduced in animals receiving co-treatment
with CsA and ADMSC.
Study limitations
This study has limitations. First, although extensive bio-
markers that play crucial roles in acute kidney IR injury
were assayed, the precise signaling pathway(s) gover-
ning the therapeutic effects of CsA treatment, ADMSC
treatment or CsA/ADMSC co-treatment have not been
elucidated. We have, however, proposed mechanisms
based on the findings of the current study, as summa-
rized in Figure 10. In this way, we speculate that the
mechanism of the enhanced protective effect of CsA-
assisted ADMSC therapy was through augmentation of
Figure 9 Western blot results of oxidative stress, antioxidant and endothelial function biomarkers in the kidney. Western blot results of
oxidative stress, antioxidant and endothelial function biomarkers in the kidney at 72 hours after ischemia–reperfusion (IR) (n = 8). (A) Oxidative
index (protein carbonyls) among five groups of animals (a = control, b = IR only, c = IR + CsA, d = IR + ADMSC, e = IR + CsA–ADMSC). (B)
*P <0.0001 vs. other groups with different symbols; † vs. ‡ vs. §, all P <0.05 for inter-group comparisons. (Note: Right lane and left lane
shown on the upper panel represent control oxidized molecular protein standard and protein molecular weight marker, respectively.) DNP,
1,3-dinitrophenylhydrazone. (C) Protein expressions of heme oxygenase (HO)-1 and (D) NAD(P)H quinone oxidoreductase (NQO)-1 among
the five groups; *P <0.001 vs. other groups with different symbols; † vs. ‡ vs. § vs. ¶, all P <0.05 for inter-group comparisons. (E) Protein
expression of endothelial nitric oxide synthase (eNOS). *P <0.001 vs. other groups with different symbols; † vs. ‡ vs. §, all P <0.05 for
inter-group comparisons. Different symbols (*, †, ‡, ¶, §) among different indicate significance at the 0.05 level. ADMSC, adipose-derived
mesenchymal stem cells; CsA, cyclosporine A.
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fect, and probably also through an effect of CsA on en-
hancing retention of ADMSCs, which in turn facilitatedthe generation of angiogenesis factors. Second, without
examining the impact of different regimens of CsA on
the setting of acute kidney IR injury, we did not know
Figure 10 Proposed mechanisms underlying therapeutic effects of cyclosporine, adipose-derived mesenchymal stem cells, and
combination therapy. Proposed mechanisms underlying therapeutic effects of cyclosporine (CsA), adipose-derived mesenchymal stem cells
(ADMSCs), and combined CsA and ADMSCs on improving renal ischemia–reperfusion. ICAM-1, intercellular adhesion molecule-1; PDGF, platelet-
derived growth factor; RANTES, regulated and normal T-cell expressed and secreted; MMP-9, matrix metalloproteinase; PGE2, prostaglandin E2;
HO-1, heme oxygenase-1; NQO, NAD(P)H quinone oxidoreductase; GR, glutathione reductase; GPx, glutathione peroxidase; NOX, NAD(P)H oxidase;
eNOS, endothelial nitric oxide synthase; SDF-1α, stromal cell-derived factor-1α; vWF, von Willebrand factor; PARP, cleaved poly(ADP-ribose)
polymerase; BUN, blood urea nitrogen.
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a low dose, a high dose or just an optimal dose. Further
investigation is recommended prior to application of this
strategic management for transplant patients to prevent
cyclosporine-related toxicity and complication, especially
during the prolonged use of this drug.
Conclusion
Our results strongly indicate that combination therapy
using both CsA and ADMSCs provided superior protec-
tion against acute IR-induced kidney injury then either
monotherapy alone. We highlight the clinical relevance
of this co-treatment regimen for patients with acute kid-
ney IR injury, especially in those experiencing rejection
of their renal transplant. Furthermore, our results may
provide important clinical relevance to the possibility ofcyclosporine withdrawal in transplant patients by adding
ADMSCs to mitigate complications of prolonged immu-
nosuppressive therapy.Abbreviations
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